REG - 600 Group PLC - Change of Adviser

600Announcement

26/01/2021 07:00

RNS Number : 8261M
  
600 Group PLC
  
26 January 2021
  
 

26 January 2021
 
The 600 Group PLC
 
Change of Adviser
 
 
The 600 Group PLC (the "Group"), the diversified industrial engineering company (AIM: SIXH), announces the appointment of Cenkos Securities plc as the Group's nominated adviser and sole broker with immediate effect. 
 
 
Enquiries:
 



The 600 Group PLC
Paul Dupee, Executive Chairman
 


Tel: 01924 415000




Instinctif Partners
Mark Garraway
Rosie Driscoll
 


Tel: 0207 457 2020




Cenkos Securities plc (Nominated Adviser and Broker)
Ben Jeynes / Max Gould (Corporate Finance)
Alex Pollen (Sales)
 


Tel: 020 7397 8900



 
About The 600 Group PLC
The 600 Group PLC is a distributor, designer and manufacturer of industrial products with three principle areas of activities:
Machine Tools
The business has a strong reputation in the market for metal turning machines. Products range from small conventional machines for education markets, CNC workshop machines and CNC production machines. Selected outsourcing partners support the manufacturing of these machines and they are marketed through the Group's wholly owned international sales organisation and a global distribution network.
Precision Engineered Components
Machine spares are distributed to customers globally to help maintain the installed base of group machines which number in excess of 100,000. Additionally, work holding products are sold via specialist distributors to OEMs, including other machine builders.
Industrial Laser Systems
Industrial laser systems cover laser marking and processing including cutting, drilling, ablation and a host of other niche applications in the marking and micro machining sectors. They require no consumables and can operate on a continuous high speed basis and can be integrated into customers' production lines. The businesses have their own technology and proprietary software. Customer applications are diverse and range from aerospace to medical and pharmaceuticals. The requirement for increased product and component traceability is one of the market drivers.
More information on the Group can be viewed at: www.600group.com  
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
APPBAMRTMTITBBB